|
|
Article: Study results from A. Ahmed and colleagues update understanding of vascular endothelial growth factor.
- Article from:
- Angiogenesis Weekly
- Article date:
- November 13, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In this recent report published in the journal Clinical and Experimental Ophthalmology, researchers in Balgat, Turkey conducted a study "To investigate the effect of bevacizumab in an experimental rabbit model of corneal neovascularization. The right eyes of 24 white New Zealand rabbits were included in a corneal neovascularization model using alkaline burn."
"They were divided into four groups. Topical bevacizumab was installed three times daily in group 1, 5 mg bevacizumab subconjunctivally every 2 days in group 2, 10 mg bevacizumab subconjunctivally every 2 days in group 3 and 0.2 cc of normal saline in the same way in group 4 (control group). All eyes were ...